Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia

Meyer-Lindenberg, Andreas, Miletich, Robert S., Kohn, Philip D., Esposito, Giuseppe, Carson, Richard E., Quarantelli, Mario, Weinberger, Daniel R., Berman, Karen Faith·2002·Nature Neuroscience

Cited by (646)

Items 101–200 of 646

  1. Role of dopamine D(2) receptors for antipsychotic activity.
    N. Ginovart, S. Kapur · 2012 · Handbook of Experimental Pharmacology
  2. α-Adrenoceptor modulation hypothesis of antipsychotic atypicality
    T. Svensson · 2003 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  3. TC-5619: An alpha7 neuronal nicotinic receptor-selective agonist that demonstrates efficacy in animal models of the positive and negative symptoms and cognitive dysfunction of schizophrenia
    Terry A. Hauser, Aaron J. Kucinski, Kristen Green-Jordan, G.J. Gatto, Scott R. Wersinger, Renae A. Hesse, Ewa K. Stachowiak, Michal K. Stachowiak, Roger L. Papke, P M Lippiello et al. · 2009 · Biochemical Pharmacology
  4. Developmental pathology, dopamine, and stress: a model for the age of onset of schizophrenia symptoms.
    Judy L. Thompson, M. Pogue-Geile, A. Grace · 2004 · Schizophrenia bulletin
  5. Presynaptic Dopamine Capacity in Patients with Treatment-Resistant Schizophrenia Taking Clozapine: An [18F]DOPA PET Study
    Euitae Kim, Oliver David Howes, Mattia Veronese, Katherine Beck, Seongho Seo, Jin Woo Park, Jae Sung Lee, Yun‐Sang Lee, Jun Soo Kwon · 2016 · Neuropsychopharmacology
  6. Catechol O-Methyltransferase (COMT) mRNA Expression in the Dorsolateral Prefrontal Cortex of Patients with Schizophrenia
    Mitsuyuki Matsumoto, Cynthia Shannon Weickert, Senda Beltaifa, Bhaskar S. Kolachana, Jingshan Chen, Thomas M. Hyde, Mary M. Herman, Daniel R. Weinberger, Joel E. Kleinman · 2003 · Neuropsychopharmacology
  7. Altered probabilistic learning and response biases in schizophrenia: Behavioral evidence and neurocomputational modeling.
    Waltz, James A., Frank, Michael J., Wiecki, Thomas V., Gold, James M. · 2011 · Neuropsychology
  8. PET Studies of Cerebral Levodopa Metabolism: A Review of Clinical Findings and Modeling Approaches
    Yoshitaka Kumakura, Paul D. Cumming · 2009 · The Neuroscientist
  9. Dysregulation of Midbrain Dopamine System and the Pathophysiology of Schizophrenia
    Susan F. Sonnenschein, Felipe V. Gomes, Anthony A. Grace · 2020 · Frontiers in Psychiatry
  10. Role of basal ganglia neurocircuitry in the pathology of psychiatric disorders
    Tom Macpherson, Takatoshi Hikida · 2019 · Psychiatry and Clinical Neurosciences
  11. Development, wiring and function of dopamine neuron subtypes
    Garritsen, Oxana, van Battum, Eljo Y., Grossouw, Laurens M., Pasterkamp, R. Jeroen · 2023 · Nature reviews. Neuroscience
  12. Impact of interacting functional variants in COMT on regional gray matter volume in human brain
    Honea, Robyn, Verchinski, Beth A., Pezawas, Lukas, Kolachana, Bhaskar S., Callicott, Joseph H., Mattay, Venkata S., Weinberger, Daniel R., Meyer-Lindenberg, Andreas · 2009 · NeuroImage
  13. Noninvasive remote activation of the ventral midbrain by transcranial direct current stimulation of prefrontal cortex
    Vikram S. Chib, Kyongsik Yun, H Takahashi, Shinsuke Shimojo · 2013 · Translational Psychiatry
  14. Striatal Presynaptic Dopamine in Schizophrenia, Part I: Meta-Analysis of Dopamine Active Transporter (DAT) Density
    Paolo Fusar‐Poli, Andreas Meyer‐Lindenberg · 2012 · Schizophrenia Bulletin
  15. Increased levels of midbrain immune-related transcripts in schizophrenia and in murine offspring after maternal immune activation
    Tertia D. Purves-Tyson, Ulrike Weber‐Stadlbauer, Juliet Richetto, Debora A. Rothmond, Marie A. Labouesse, Marcello Polesel, Kate Robinson, Cynthia Shannon Weickert, Urs Meyer · 2019 · Molecular Psychiatry
  16. Measurement of Brain Regional α-[11C]Methyl-L-Tryptophan Trapping as a Measure of Serotonin Synthesis in Medication-FreePatients With Major Depression
    Pedro Rosa‐Neto, Mirko Dikšić, Hidehiko Okazawa, Marco Leyton, Nayyer Ghadirian, Shadreck Mzengeza, Akio Nakai, Guy Debonnel, Pierre Blier, Chawki Benkelfat · 2004 · Archives of General Psychiatry
  17. DRD2 polymorphisms modulate reward and emotion processing, dopamine neurotransmission and openness to experience
    Peciña, Marta, Mickey, Brian J., Love, Tiffany, Wang, Heng, Langenecker, Scott A., Hodgkinson, Colin, Shen, Pei-Hong, Villafuerte, Sandra, Hsu, David, Weisenbach, Sara L. et al. · 2013 · Cortex
  18. The neural underpinnings of cognitive flexibility and their disruption in psychotic illness
    Waltz, James A. · 2017 · Neuroscience
  19. The impact of Disrupted-in-Schizophrenia 1 (DISC1) on the dopaminergic system: a systematic review
    T. Dahoun, Svenja V. Trossbach, N. Brandon, Carsten Korth, O. Howes · 2017 · Translational Psychiatry
  20. Mad genius revisited: Vulnerability to psychopathology, biobehavioral approach-avoidance, and creativity.
    Matthijs Baas, B. Nijstad, N. Boot, C. D. De Dreu · 2016 · Psychological bulletin
  21. Effects of High-Frequency Transcranial Magnetic Stimulation for Cognitive Deficit in Schizophrenia: A Meta-Analysis
    Yi Jiang, Zhiwei Guo, Guoqiang Xing, Lin He, Haitao Peng, Fei Du, Morgan A. McClure, Qiwen Mu · 2019 · Frontiers in Psychiatry
  22. Intramembrane receptor–receptor interactions: a novel principle in molecular medicine
    Kjell Fuxé, Meritxell Canals, Maria Torvinen, Daniel J. Marcellino, Anton Terasmaa, Susanna Genedani, Giuseppina Leo, Diego Guidolin, Zaida Dı́az-Cabiale, Alicia Rivera et al. · 2006 · Journal of Neural Transmission
  23. Interindividual Differences in Functional Interactions among Prefrontal, Parietal and Parahippocampal Regions during Working Memory
    Michael F. Glabus · 2003 · Cerebral Cortex
  24. Does dopamine mediate the psychosis-inducing effects of cannabis? A review and integration of findings across disciplines
    Kuepper, Rebecca, Morrison, Paul D., van Os, Jim, Murray, Robin M., Kenis, Gunter, Henquet, Cécile · 2010 · Schizophrenia Research
  25. The role of monoamine oxidase enzymes in the pathophysiology of neurological disorders
    Danielle N. Jones, Mary Ann Raghanti · 2021 · Journal of Chemical Neuroanatomy
  26. Clinical and positron emission tomography of Parkinson's disease caused by LRRK2
    Dena G. Hernandez, Coro Paisán‐Ruiz, Aideen M McInerney-Leo, Shushant Jain, Andreas Meyer‐Lindenberg, E. Whitney Evans, Karen Faith Berman, Janel O. Johnson, Georg W. J. Auburger, Alejandro A. Schäffer et al. · 2005 · Annals of Neurology
  27. Abnormal social behaviors in mice lacking Fgf17
    Kimberly A. Scearce-Levie, Erik D. Roberson, Hertzel C. Gerstein, Jeremy A. Cholfin, Vidya S Mandiyan, Nirao M. Shah, John L.R. Rubenstein, Lennart Mucke · 2007 · Genes Brain & Behavior
  28. Midbrain dopaminergic neurons: determination of their developmental fate by transcription factors.
    Horst H. Simon, Lavinia Bhatt, Daniel Gherbassi, Paola Sgadó, Lavinia Auber Alberi · 2003 · PubMed
  29. The effects of psychosocial stress on dopaminergic function and the acute stress response
    Bloomfield, Michael AP, McCutcheon, Robert A, Kempton, Matthew, Freeman, Tom P, Howes, Oliver · 2019 · eLife
  30. Increased Macrophages and C1qA, C3, C4 Transcripts in the Midbrain of People With Schizophrenia
    Tertia D. Purves-Tyson, Kate Robinson, Amelia M. Brown, Danny Boerrigter, Helen Q. Cai, Christin Weissleder, Samantha J. Owens, Debora A. Rothmond, Cynthia Shannon Weickert · 2020 · Frontiers in Immunology
  31. Effects of Psychotic State and Task Demand on Prefrontal Function in Schizophrenia: An fMRI Study of Overt Verbal Fluency
    Cynthia H.Y. Fu, John Suckling A, Steven Williams, Chris Andrew, Goparlen N. Vythelingum, Philip K. McGuire · 2005 · American Journal of Psychiatry
  32. Subchronic and chronic PCP treatment produces temporally distinct deficits in attentional set shifting and prepulse inhibition in rats
    Alice Egerton, Lee Reid, Sandie McGregor, Susan M. Cochran, BRIAN J. MORRIS, Judith A. Pratt · 2008 · Psychopharmacology
  33. Oxytocin in schizophrenia: a review of evidence for its therapeutic effects
    Kai S. MacDonald, David Feifel · 2011 · Acta Neuropsychiatrica
  34. Subchronic Haloperidol Downregulates Dopamine Synthesis Capacity in the Brain of Schizophrenic Patients In Vivo
    Gerhard Gründer, Ingo Vernaleken, Matthias J. Müller, Eugen Davids, Nilufar Heydari, Hans‐Georg Buchholz, Peter Bartenstein, Ole Lajord Munk, Peter Stoeter, Dean Foster Wong et al. · 2002 · Neuropsychopharmacology
  35. Habit and Skill Learning in Schizophrenia: Evidence of Normal Striatal Processing With Abnormal Cortical Input
    Thomas Wesley Weickert, Alejandro Terrazas, Llewellyn B. Bigelow, James D. Malley, Thomas M. Hyde, Michael F. Egan, Daniel R. Weinberger, Terry E. Goldberg · 2002 · Learning & Memory
  36. Striatal Response to Reward Anticipation
    Oliver Grimm, Andreas Heinz, Henrik Walter, Peter Kirsch, Susanne Erk, Leila Haddad, Michael M. Plichta, Nina Romanczuk‐Seiferth, Lydia Pöhland, Sebastian Mohnke et al. · 2014 · JAMA Psychiatry
  37. Theranostic Biomarkers for Schizophrenia
    Matea Nikolac Perković, Gordana Nedić Erjavec, Dubravka Švob Štrac, S. Uzun, O. Kozumplik, N. Pivac · 2017 · International Journal of Molecular Sciences
  38. Functional Polymorphisms in PRODH Are Associated with Risk and Protection for Schizophrenia and Fronto-Striatal Structure and Function
    Lucas Kempf, Kristin K. Nicodemus, Bhaskar S. Kolachana, Radhakrishna Vakkalanka, Beth A. Verchinski, Michael F. Egan, Richard E. Straub, Venkata Satyanand Mattay, Joseph H. Callicott, Daniel R. Weinberger et al. · 2008 · PLoS Genetics
  39. Distribution of mGluR1α and mGluR5 immunolabeling in primate prefrontal cortex
    E. Chris Muly, Marcelia Maddox, Yoland Smith · 2003 · The Journal of Comparative Neurology
  40. Dopamine Activates Noradrenergic Receptors in the Preoptic Area
    Charlotte Anne Cornil, Jacques Balthazart, Patrick Motté, Laurent Massotte, Vincent Seutin · 2002 · Journal of Neuroscience
  41. Reproducing the dopamine pathophysiology of schizophrenia and approaches to ameliorate it: a translational imaging study with ketamine
    Michelle Kokkinou, Elaine E. Irvine, David R. Bonsall, Sridhar Natesan, Lisa A. Wells, Mark Smith, Justyna A. Glegola, Eleanor J. Paul, Kyoko Tossell, Mattia Veronese et al. · 2020 · Molecular Psychiatry
  42. Perinatal risks and childhood premorbid indicators of later psychosis: Next steps for early psychosocial interventions
    Liu, Cindy H., Keshavan, Matcheri S., Tronick, Ed, Seidman, Larry J. · 2015 · Schizophrenia Bulletin
  43. Neuroimaging in Psychiatric Disorders
    Joseph C. Masdeu · 2011 · Neurotherapeutics
  44. Ventral striatal prediction error signaling is associated with dopamine synthesis capacity and fluid intelligence
    Florian Schlagenhauf, Michael A. Rapp, Quentin J. M. Huys, Anne Beck, Torsten Wüstenberg, Lorenz Deserno, Hans‐Georg Buchholz, Jan Kalbitzer, Ralph Buchert, Michael Bauer et al. · 2012 · Human Brain Mapping
  45. Ventral striatal activation during attribution of stimulus saliency and reward anticipation is correlated in unmedicated first episode schizophrenia patients
    Christine Esslinger, Susanne Englisch, Dragoš Inta, Franziska Rausch, Frederike N. Schirmbeck, Daniela U. Mier, Peter Kirsch, Andreas Meyer‐Lindenberg, Mathias Zink · 2012 · Schizophrenia Research
  46. Unique and shared roles of the posterior parietal and dorsolateral prefrontal cortex in cognitive functions
    Fumi Katsuki · 2012 · Frontiers in Integrative Neuroscience
  47. White matter tract abnormalities between rostral middle frontal gyrus, inferior frontal gyrus and striatum in first-episode schizophrenia
    Quan, Meina, Lee, Sang-Hyuk, Kubicki, Marek, Kikinis, Zora, Rathi, Yogesh, Seidman, Larry J., Mesholam-Gately, Raquelle I., Goldstein, Jill M., McCarley, Robert W., Shenton, Martha E. et al. · 2013 · Schizophrenia Research
  48. Genetically Determined Measures of Striatal D2 Signaling Predict Prefrontal Activity during Working Memory Performance
    Alessandro Bertolino, Paolo Taurisano, Nicola Marco Pisciotta, Giuseppe Blasi, Leonardo Fazio, Raffaella Romano, Barbara Gelao, Luciana Lo Bianco, Madia Lozupone, Annabella Di Giorgio et al. · 2010 · PLoS ONE
  49. Social Adversity in the Etiology of Psychosis: A Review of the Evidence
    Eleanor Longden, John Read · 2016 · American Journal of Psychotherapy
  50. Language disturbances in schizophrenia: the relation with antipsychotic medication
    Janna N. de Boer, Alban Voppel, Sanne Brederoo, Frank N. K. Wijnen, Iris E. Sommer · 2020 · Schizophrenia
  51. The Dopamine System and the Pathophysiology of Schizophrenia: A Basic Science Perspective
    Yukiori Goto, Anthony A. Grace · 2007 · International review of neurobiology
  52. Acetylcholine actions in the dorsomedial striatum support the flexible shifting of response patterns
    Michael E. Ragozzino · 2003 · Neurobiology of Learning and Memory
  53. Molecular substrates of schizophrenia: homeostatic signaling to connectivity
    Melissa A. Landek‐Salgado, Travis E. Faust, Akira Sawa · 2015 · Molecular Psychiatry
  54. N-acetyl cysteine restores brain glutathione loss in combined 2-cyclohexene-1-one and d-amphetamine-treated rats: Relevance to schizophrenia and bipolar disorder
    Olivia May Dean, Maarten van den Buuse, Michael Berk, David Copolov, Christine Mavros, Ashley Ian Bush · 2011 · Neuroscience Letters
  55. The Wisconsin Card Sorting impairment in schizophrenia is evident in the first four trials
    Kristen J. Prentice, James M. Gold, Robert W. Buchanan · 2008 · Schizophrenia Research
  56. NMDA Receptor Internalization by Autoantibodies: A Reversible Mechanism Underlying Psychosis?
    Joseph C. Masdeu, Josep O. Dalmau, Karen Faith Berman · 2016 · Trends in Neurosciences
  57. Transcriptional regulation of mesencephalic dopaminergic neurons: The full circle of life and death
    Kambiz N. Alavian, Christian Scholz, Horst H. Simon · 2007 · Movement Disorders
  58. Clozapine increases both acetylcholine and dopamine release in rat ventral hippocampus: role of 5-HT1A receptor agonism
    Young‐Chul Chung, Zhu Li, Jin Dai, Herbert Y. Meltzer, Junji Ichikawa · 2004 · Brain Research
  59. Midbrain Dopaminergic Neurons
    Horst H. Simon, Lavinia Bhatt, Daniel Gherbassi, Paola Sgadó, Lavinia Auber Alberi · 2003 · Annals of the New York Academy of Sciences
  60. Epistasis between the DAT 3′ UTR VNTR and the COMT Val158Met SNP on cortical function in healthy subjects and patients with schizophrenia
    Diana Pinto Prata, Andrea Mechelli, Cynthia H.Y. Fu, Marco Picchioni, Timothea Toulopoulou, Elvira Bramon, Muriel Walshe, Robin M. Murray, David Andrew Collier, Philip K. McGuire · 2009 · Proceedings of the National Academy of Sciences
  61. Expression of the ionotropic glutamate receptor subunits and NMDA receptor-associated intracellular proteins in the substantia nigra in schizophrenia.
    H. T. Mueller, V. Haroutunian, K. Davis, J. Meador-Woodruff · 2004 · Brain Research. Molecular Brain Research
  62. Transcranial direct current stimulation may modulate extinction memory in posttraumatic stress disorder
    Mascha van ‘t Wout‐Frank, Sharon M. Longo, Madhavi K. Reddy, Noah S. Philip, Marguerite Bowker, Benjamin David Greenberg · 2017 · Brain and Behavior
  63. Behavioral and morphological alterations following neonatal excitotoxic lesions of the medial prefrontal cortex in rats
    Miriam Schneider, Michael Koch · 2005 · Experimental Neurology
  64. Abnormal Striatal Dopamine Transmission in Schizophrenia
    J. Brunelin, S. Fecteau, M. Suaud-Chagny · 2013 · Current Medicinal Chemistry
  65. Prevention and Schizophrenia--The Role of Dietary Factors
    John Joseph McGrath, Amy Brown, David St Clair · 2010 · Schizophrenia Bulletin
  66. Biocompatible sulfur nitrogen co-doped carbon quantum dots for highly sensitive and selective detection of dopamine
    Cunjin Wang, Huanxian Shi, Min Yang, Zhuoru Yao, Bin Zhang, Enzhou Liu, Xiaoyun Hu, Weiming Xue, Jun Fan · 2021 · Colloids and Surfaces B Biointerfaces
  67. Putative presynaptic dopamine dysregulation in schizophrenia is supported by molecular evidence from post-mortem human midbrain
    Tertia D. Purves-Tyson, Samantha J. Owens, Debora A. Rothmond, Glenda Margaret Halliday, Kay L. Double, Julia Stevens, Toni McCrossin, Cynthia Shannon Weickert · 2017 · Translational Psychiatry
  68. Abnormalities in the dopamine system in schizophrenia may lie in altered levels of dopamine receptor-interacting proteins
    Jie Bai, Fang He, Svetlana I. Novikova, Ashiwel S. Undie, Stella M. Dracheva, Vahram H. Haroutunian, Michael S. Lidow · 2004 · Biological Psychiatry
  69. Neuregulin-1 and schizophrenia in the genome-wide association study era
    Md Shaki Mostaid, David Lloyd, Benny Liberg, Suresh Sundram, Avril M. Pereira, Christos Pantelis, Tim Karl, Cynthia Shannon Weickert, Ian Everall, Chad Bousman · 2016 · Neuroscience & Biobehavioral Reviews
  70. A Critique of the Dopamine Hypothesis of Schizophrenia and Psychosis
    Joanna Moncrieff · 2009 · Harvard Review of Psychiatry
  71. Neural Correlates of Probabilistic Category Learning in Patients with Schizophrenia
    Thomas Wesley Weickert, Terry E. Goldberg, Joseph H. Callicott, Qiang Chen, Jose A. Apud, Sumitra Das, Brad J. Zoltick, Michael F. Egan, Martijn Meeter, Catherine E. Myers et al. · 2009 · Journal of Neuroscience
  72. Dopamine, fronto-striato-thalamic circuits and risk for psychosis
    Orwa Dandash, Christos Pantelis, Alex Fornito · 2016 · Schizophrenia Research
  73. Does Therapeutic Repetitive Transcranial Magnetic Stimulation Cause Cognitive Enhancing Effects in Patients with Neuropsychiatric Conditions? A Systematic Review and Meta-Analysis of Randomised Controlled Trials
    Martin, Donel M., McClintock, Shawn M., Forster, Jane, Loo, Colleen K. · 2016 · Neuropsychology Review
  74. Crosstalk between the transcriptional regulation of dopamine D2 and cannabinoid CB1 receptors in schizophrenia: Analyses in patients and in perinatal Δ9-tetrahydrocannabinol-exposed rats
    Martina Di Bartolomeo, Tibor Štark, Oriana Maria Maurel, Fabio Arturo Iannotti, Martin Kuchař, Jana Kučerová, Fabiana Piscitelli, Samuele Laudani, Vladimír Pekařík, Salvatore Salomone et al. · 2020 · Pharmacological Research
  75. Microvascular anomaly conditions in psychiatric disease. Schizophrenia – angiogenesis connection
    Pavel Katsel, Panos Roussos, Mikhail V. Pletnikov, Vahram H. Haroutunian · 2017 · Neuroscience & Biobehavioral Reviews
  76. Dopaminergic control of working memory and its relevance to schizophrenia: a circuit dynamics perspective.
    Shoji Tanaka · 2006 · Neuroscience
  77. Phosphodiesterase inhibition and modulation of corticostriatal and hippocampal circuits: Clinical overview and translational considerations
    Pim R.A. Heckman, Arjan Blokland, Eva Bollen, Jos Prickaerts · 2018 · Neuroscience & Biobehavioral Reviews
  78. The Role of Extrastriatal Dopamine D2 Receptors in Schizophrenia
    Hidehiko Takahashi, Makoto Higuchi, Tetsuya Suhara · 2006 · Biological Psychiatry
  79. Remediation of attentional dysfunction in rats with lesions of the medial prefrontal cortex by intra-accumbens administration of the dopamine D2/3 receptor antagonist sulpiride
    Marie A. Pezze, Jeffrey W. Dalley, Trevor William Robbins · 2008 · Psychopharmacology
  80. Effects of Prefrontal Cortical Inactivation on Neural Activity in the Ventral Tegmental Area
    Yong Sang Jo, Jane Jean-Hee Lee, Sheri J. Y. Mizumori · 2013 · Journal of Neuroscience
  81. Schizophrenia: From the brain to peripheral markers. A consensus paper of the WFSBP task force on biological markers
    Gerald Stoeber, Dorit Ben‐Shachar, Michal Cardon, Peter Falkai, Alfred Nji Fonteh, Micha Gawlik, Birte Yding Glenthoj, Edna Grünblatt, Assen V Jablensky, Yong‐Ku Kim et al. · 2009 · The World Journal of Biological Psychiatry
  82. Stereological studies of capillary length density in the frontal cortex of schizophrenics
    Paweł Kreczmański, Rainald Schmidt‐Kastner, Helmut Heinsen, Harry W.M. Steinbusch, Patrick R. Hof, Christoph Schmitz · 2005 · Acta Neuropathologica
  83. Context-dependent cortical activation in response to financial reward and penalty: an event-related fMRI study
    Akitsuki, Yuko, Sugiura, Motoaki, Watanabe, Jobu, Yamashita, Keiichi, Sassa, Yuko, Awata, Shuichi, Matsuoka, Hiroo, Maeda, Yasuhiro, Matsue, Yoshihiko, Fukuda, Hiroshi et al. · 2003 · NeuroImage
  84. A Systems Neuroscience Perspective of Schizophrenia and Bipolar Disorder
    Sophia Frangou · 2014 · Schizophrenia Bulletin
  85. The relationship between immune and cognitive dysfunction in mood and psychotic disorder: a systematic review and a meta-analysis
    Manuel Morrens, C. Overloop, Violette Coppens, Elke Loots, Minne Van Den Noortgate, S. Vandenameele, Marion Leboyer, Livia De Picker · 2022 · Molecular Psychiatry
  86. Positron Emission Tomography in Schizophrenia: A New Perspective
    N. Patel, N. S. Vyas, B. Puri, K. Nijran, A. Al-nahhas · 2010 · Journal of Nuclear Medicine
  87. Fibroblast growth factor receptor signaling affects development and function of dopamine neurons – inhibition results in a schizophrenia‐like syndrome in transgenic mice
    I. Klejbor, Jason M. Myers, K. Hausknecht, Thomas D. Corso, Angelo S. Gambino, J. Moryś, P. Maher, R. Hard, Jerry C. Richards, E. Stachowiak et al. · 2006 · Journal of Neurochemistry
  88. Asymmetry in dopamine D2/3 receptors of caudate nucleus is lost with age
    Ingo Vernaleken, Carsten Weibrich, Thomas Siessmeier, Hans‐Georg Buchholz, Frank Rösch, Andreas Heinz, Paul D. Cumming, Peter Stoeter, Peter Bartenstein, Gerhard Gründer · 2006 · NeuroImage
  89. Novel truncated isoform of SK3 potassium channel is a potent dominant-negative regulator of SK currents: implications in schizophrenia
    Hiroaki Tomita, Vikram G. Shakkottai, George A. Gutman, Guoqiang Sun, William E. Bunney, Michael D. Cahalan, K. George Chandy, John Jay Gargus · 2003 · Molecular Psychiatry
  90. Maternal Immune Activation and the Development of Dopaminergic Neurotransmission of the Offspring: Relevance for Schizophrenia and Other Psychoses
    A. Aguilar-Valles, Brandon Rodrigue, E. Matta-Camacho · 2020 · Frontiers in Psychiatry
  91. Are genetic variants of COMT associated with addiction?
    Anne Tammimäki, Pekka T. Männistö · 2010 · Pharmacogenetics and Genomics
  92. The Neurocognitive Cost of Enhancing Cognition with Methylphenidate: Improved Distractor Resistance but Impaired Updating
    Sean James Fallon, Marieke E. van der Schaaf, Niels ter Huurne, Roshan Cools · 2016 · Journal of Cognitive Neuroscience
  93. Transdiagnostic Prediction of Affective, Cognitive, and Social Function Through Brain Reward Anticipation in Schizophrenia, Bipolar Disorder, Major Depression, and Autism Spectrum Diagnoses
    Kristina Schwarz, Carolin Moessnang, Janina Isabel Schweiger, Sarah Baumeister, Michael M. Plichta, Daniel Brandeis, Tobias Banaschewski, Carolin Wackerhagen, Susanne Erk, Henrik Walter et al. · 2019 · Schizophrenia Bulletin
  94. Opposite Effects of Catechol-O-Methyltransferase Val158Met on Cortical Function in Healthy Subjects and Patients with Schizophrenia
    Diana Pinto Prata, Andrea Mechelli, Cynthia H.Y. Fu, Marco Picchioni, Fergus Kane, Sridevi Kalidindi, Colm McDonald, Oliver David Howes, Eugenia Kravariti, Arsime Demjaha et al. · 2008 · Biological Psychiatry
  95. Classification of schizophrenic patients and healthy controls using [18F] fluorodopa PET imaging.
    S. Bose, F. Turkheimer, O. Howes, M. Mehta, R. Cunliffe, Paul R. A. Stokes, P. Grasby · 2008 · Schizophrenia Research
  96. Presynaptic regulation of dopamine transmission in schizophrenia.
    G. Lyon, A. Abi-Dargham, Holly Moore, Jeffrey A. Lieberman, J. Javitch, David Sulzer · 2011 · Schizophrenia bulletin
  97. 3D‐Ridge Stocked Layers of Nitrogen‐Doped Mesoporous Carbon Nanosheets for Ultrasensitive Monitoring of Dopamine Released from PC12 Cells under K+ Stimulation
    Mohammed Y. Emran, Mohamed A. Shenashen, Hiromi Morita, Sherif A. El‐Safty · 2018 · Advanced Healthcare Materials
  98. The dopamine dysfunction in schizophrenia revisited: new insights into topography and course.
    R. Kuepper, M. Skinbjerg, A. Abi-Dargham · 2012 · Handbook of Experimental Pharmacology
  99. Complementary and Alternative Medicine (CAM)
    Marlene P. Freeman · 2009 · The Journal of Clinical Psychiatry
  100. Role of netrin-1 in the organization and function of the mesocorticolimbic dopamine system
    Cecilia Flores · 2011 · Journal of Psychiatry and Neuroscience